share_log

Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Farokhzad Omid

SEC ·  Jul 13 04:22
Summary by Futu AI
On July 10, 2024, Farokhzad Omid engaged in a transaction involving Senti Biosciences, Inc. (SNTI). The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Farokhzad Omid to the issuer was also not specified. Without these details, the impact of this transaction on Farokhzad Omid's holdings and on Senti Biosciences remains unclear to investors.
On July 10, 2024, Farokhzad Omid engaged in a transaction involving Senti Biosciences, Inc. (SNTI). The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Farokhzad Omid to the issuer was also not specified. Without these details, the impact of this transaction on Farokhzad Omid's holdings and on Senti Biosciences remains unclear to investors.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.